Mirabegron
Showing 1 - 25 of 166
Resting Energy Expenditure, Thermogenesis, Brown Adipose Tissue Trial in Bloomington (Mirabegron, Placebo)
Recruiting
- Resting Energy Expenditure
- +2 more
- Mirabegron
- Placebo
-
Bloomington, IndianaIndiana University
Aug 4, 2023
Postural Orthostatic Tachycardia Syndrome, Chronic Orthostatic Intolerance, Syncope Trial in Los Angeles (Mirabegron 50 MG,
Not yet recruiting
- Postural Orthostatic Tachycardia Syndrome
- +2 more
- Mirabegron 50 MG
- Mirabegron 25 MG
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 14, 2023
Tumour Trial in Hangzhou (Mirabegron)
Recruiting
- Tumour
- Mirabegron
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Mar 9, 2023
Female Patients With Overactive Bladder Syndrome Trial in Banqiao (tolterodine, mirabegron, tolterodine , mirabegron)
Not yet recruiting
- Female Patients With Overactive Bladder Syndrome
- tolterodine
- +2 more
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jul 13, 2023
Overactive Bladder, Overactive Bladder Syndrome Trial in Maribor (mirabegron 50 mg daily, Extracorporeal magnetic innervation
Completed
- Overactive Bladder
- Overactive Bladder Syndrome
- mirabegron 50 mg daily
- +2 more
-
Maribor, SloveniaUniversity Medical Centre Maribor
Nov 8, 2023
Healthy Trial in Soeul (DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg)
Not yet recruiting
- Healthy
- DA-8010 5mg
- +2 more
-
Soeul, Korea, Republic ofSeoul National University Hospital
Aug 7, 2023
Ureteral Stone, Kidney Stones, Ureteral Stenosis Trial in Makassar (Mirabegron 50 MG)
Completed
- Ureteral Stone
- +2 more
- Mirabegron 50 MG
-
Makassar, South Sulawesi, IndonesiaDR Wahidin Sudirohusodo Hospital, Hasanuddin University Hospital
Nov 8, 2023
Thermoregulation Trial in Fort Collins (Myrbetriq 25Mg Extended-Release Tablet, Placebo)
Recruiting
- Thermoregulation
- Myrbetriq 25Mg Extended-Release Tablet
- Placebo
-
Fort Collins, ColoradoColorado State University
Aug 21, 2023
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Intracerebral Haemorrhage Trial (mirabegron, usual care)
Not yet recruiting
- Intracerebral Haemorrhage
- mirabegron
- usual care
- (no location specified)
Oct 18, 2022
Nephrolithiasis Trial in Halifax (Mirabegron, Tamsulosin, Tylenol #3)
Completed
- Nephrolithiasis
- Mirabegron
- +2 more
-
Halifax, Nova Scotia, CanadaNova Scotia Health Authority, Central
Nov 4, 2022
Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR
Completed
- Healthy
- Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
- +2 more
-
Cairo, EgyptGenuine Research Center GRC
Mar 2, 2023
Insulin Resistance, Obesity Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Placebo,
Not yet recruiting
- Insulin Resistance
- Obesity
- Placebo
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 10, 2023
Overactive Bladder Trial (mirabegron)
Not yet recruiting
- Overactive Bladder
- mirabegron
- (no location specified)
Jul 6, 2022
Nocturnal Enuresis Trial in Banha (desmopressin 120 mcg oral tablets, Mirabegron 25 MG Oral Tablet, Extended Release, behavioral
Recruiting
- Nocturnal Enuresis
- desmopressin 120 mcg oral tablets
- +2 more
-
Banhā, Qaliopia, EgyptBenha University Hospitals
Nov 29, 2022
Voiding Disorders Trial in Mansoura (Mirabegron, Propevirine, Solifenacin)
Recruiting
- Voiding Disorders
- Mirabegron, Propevirine, Solifenacin
-
Mansoura, EgyptUrology and Nephrology Center, Mansoura University
Aug 3, 2022
Type 2 Diabetes Trial in Sherbrooke (Mirabegron, Bisoprolol Fumarate)
Completed
- Type 2 Diabetes
- Mirabegron
- Bisoprolol Fumarate
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Oct 31, 2022
Overactive Bladder Trial in Cleveland (electroacupncture, Mirabegron 50 MG [Myrbetriq])
Withdrawn
- Overactive Bladder
- electroacupncture
- Mirabegron 50 MG [Myrbetriq]
-
Cleveland, OhioUniversity Hospitals Case Medical Center
May 2, 2022
Urinary Bladder, Overactive, Urinary Incontinence, Accidental Falls Trial in Galveston (Pelvic Floor Muscle Training,
Not yet recruiting
- Urinary Bladder, Overactive
- +2 more
- Pelvic Floor Muscle Training
- +2 more
-
Galveston, TexasUniversity of Texas Medical Branch at Galveston
May 30, 2023
Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)
Not yet recruiting
- Neurogenic Detrusor Overactivity
- mirabegron
-
Palo Alto, California
- +11 more
Jan 16, 2023
Solifenacin or Mirabegron in Overactive Bladder Syndrome
Recruiting
- Overactive Bladder Syndrome
- Solifenacin Oral Tablet
- Mirabegron 25mg
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Mar 9, 2022
Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,
Recruiting
- Urinary Bladder, Overactive
- +2 more
- Intradetrusor Botox® (onabotulinumtoxinA) injection
- Combine Mirabegron and Solifenacin.
-
Taipei, TaiwanMackay Memorial Hospital
Jul 29, 2023
Pre-diabetes, Obesity Trial in Lexington (Mirabegron 50 MG, Tadalafil 10 MG, Placebo)
Recruiting
- Pre-diabetes
- Obesity
- Mirabegron 50 MG
- +2 more
-
Lexington, KentuckyUniversity of Kentucky
Dec 13, 2021
Overactive Bladder Syndrome Trial in Taipei City (mirabegron, TTNS)
Recruiting
- Overactive Bladder Syndrome
- mirabegron
- TTNS
-
Taipei City, TaiwanTaipei Veterans General Hospital
Dec 27, 2021
Pharmacokinetics of Mirabegron, Food Effect, Healthy Chinese Subjects Trial in Shanghai (mirabegron)
Completed
- Pharmacokinetics of Mirabegron
- +2 more
- mirabegron
-
Shanghai, ChinaSite CN86001
Nov 10, 2021